Endomag named as one of the UK’s fastest growing tech companies once again

Inside London’s new COVID-free ‘hubs’: Part 2 – a safe place for collaboration and innovation

Inside London’s new COVID-free ‘hubs’: Part 1 – a new home for UK breast cancer care

Magtrace® and Sentimag® platform shortlisted for award – ‘Best Medical Technology’

Tracing a revolution: how Magseed® and Magtrace® are improving cancer care across Europe

A ‘game-changer’ for breast surgery: Southern Maine Health Care share their first experiences with Magtrace®

Seeds vs. wires for breast localization – latest data supports Magseed® adoption

UK’s most-read Sunday newspaper features pioneering breast cancer procedure using the Magseed® marker

Accelerating innovation: How Hampshire Hospitals are driving higher breast care standards

Learning from a pandemic: are new breast cancer strategies here to stay?

The clinical case for TAD: management of the axilla post-NAC

Why the Magseed® marker is ideal for reconstructive breast surgery – an interview in Plastic Surgery Practice

Managing COVID-19: How Manchester’s Nightingale Centre is operating quicker than ever before

What impact does neoadjuvant chemotherapy have on the axilla? Prof. Alastair Thompson shares his expert advice

“How I coped with breast cancer” – survivor Maria opens up on her experience in the UK’s Sunday Mirror

Dr Kandace McGuire, MD of VCU Massey Cancer Center reveals how she’s changing the standard of breast surgery

Our opportunity to support the NHS at this time

Going the distance: how Magtrace® and Magseed® are helping rural communities

The remarkable career of Richard Rainsbury honoured at Festschrift

An inspiring couple’s donation to advance breast cancer treatment

Magseed® marker featured on world’s largest newspaper website

European breast cancer patients can now access more convenient and targeted treatment with new Magseed® marker indication

Baylor St. Luke’s Medical Center in Texas adopts our Sentimag localisation system

Endomag in Kenya: Giving new access to the best standards of breast cancer care

Breast screening and self-checks make all the difference

Meet Scott and his team, our commercial support in North America

Reducing stress in breast cancer care with wireless localisation surgery

“Unbelievably convenient” – The Magseed marker feedback that means the world to us

SSM Health puts patients first with advanced breast cancer treatments

Cycling 3000 miles across America in just 9 days for breast cancer research

Why is improving breast cancer care so important to us?

Magtrace® lymphatic tracer shortlisted as US Prix Galien ‘Best Medical Technology’ finalist

Let’s talk about black women and breast cancer: the inaugural conference

Endomag wins Barclays Entrepreneur Award for ‘International Expansion of the Year’

Exhibiting at CoBrCa – the Controversies in Breast Cancer Congress in San Francisco

Endomag named in UK’s top 100 fastest growing tech companies league table

‘London Calling’ for the annual London Breast Meeting

Telling our story on the HS. Health-Tech podcast

Pioneering Surgical Guidance System from Endomag Wins Institute of Physics’ Business Innovation Award

October marks the start of Endomag’s triathlon challenge

Breast Cancer Device Receives FDA Approval

Endomag raises $10 million (£8m) Series C funding led by Draper Esprit to establish a new standard of breast cancer care

Endomag wins Queen’s Award

University Hospitals System Widens Use of Magseed® Marker

World First for Magseed®

Endomag receives CE Mark for Magseed®

Ochsner Health System adopts Magseed®

Endomag Strengthens Board with Key Appointment

UCSF Adopts Magseed® as Standard of Care

US Multi-Centre Trial Published at SABCS 2016

IOP Commended Innovation Award win

Endomag and Devicor Medical Products Announce Distribution Agreement

FDA 510(k) Clearance Granted for Endomag’s Breast Tumor Localization System

Endomag completes patient enrolment of U.S. pivotal trial for Sentimag® and Sienna+®

Endomag scoops business award for innovation

Lord Sainsbury opens Endomag’s Cambridge headquarters

Endomag selected as finalist for top engineering award

Endomag opens two new offices

Endomag’s Sentimag® trial begins in the US

Endomag to present at influential OneMedForum in San Francisco

Endomagnetics becomes Endomag as business expands into new markets

Endomagnetics receives IDE approval to initiate US trials

Endomagnetics Raises Further Funding for US Clinical Trial, Sales Support and New Product Development

Endomagnetics Completes Acquisition of the ACT Portfolio

Endomagnetics Introduces Higher Performance Probe and Makes CTO Appointment

Another Major Award for Endomagnetics

Endomagnetics Wins Business Award for Best New Product

Endomagnetics Shortlisted for Business Awards

Central-European Trial Publishes